- Projects & figures
- News & Events
- Managing your project
- About ERC
Could migration lead to more respect for ethnic and cultural diversity not only in receiving communities but also in sending countries? By observing the effects of Polish migration to the UK and Germany, as a result of the country’s entry in the EU in 2004, Prof. Magdalena Nowicka explores possible answers to this question.
Prof. Gregoire Courtine believes paralysed patients will be able to walk again. This belief has represented the focus of years of work aimed at regenerating the functions of the spinal cord after injury. Thanks to his ERC funding in both 2010 and 2015, Prof. Courtine and his team have been able to develop so-called “personalised neuroprosthetics” that have led immobile rats, and more recently monkeys, to overcome their paralysis.
Magdalena Król is Professor at the Faculty of Veterinary Medicine of the Warsaw University of Life Sciences (SGGW) in Poland. She specializes in cancer research. Since 2006 Professor Król and her team have been investigating canine mammary cancer with particular focus on cancer metastasis and tumor microenvironment. Now she develops innovative cell-based method of drug delivery to solid tumors. Her discoveries about interactions between immune cells and cancer cells may one day revolutionize the treatment of cancer.
Originally published in March 2017 as part of the multimedia campaign "ERC - 10 years – 10 portraits."
European researchers have designed brain-like artificial neural networks capable of numerical and spatial cognition and written language processing without any explicit training or pre-programming. Their work, based on the machine-learning approach of generative models, significantly advances the development of self-learning artificial intelligence, while also deepening understanding of human cognition.
Antibiotics are amongst the most crucial discoveries in modern medicine. However, the surge in microbial resistance to these, now common, drugs is a challenge that medical researchers work hard to tackle. Prof. Susanne Häußler from the Helmholtz Centre for Infection Research believes early diagnostic tools could shift the paradigm of how we battle this problem.
Parents may threat at the idea of their children playing in fields and sheds, but research shows that those who grew up in farms, where this is common occurrence, are less likely to suffer from allergies and asthma. Prof. Erika von Mutius leads a team of researchers, that uses this knowledge to investigate how we could treat such conditions more effectively.
Thousands of new cases of head-and-neck cancer - which includes cancer of the larynx, throat, mouth, nose and salivary glands - are diagnosed every year in Europe. Despite improvements in diagnostic and therapeutic tools, these malignant tumours still show high resistance to current treatments. Dr Daniela Thorwarth is working on tailored therapies for individual patients.
An ERC-funded project is conducting groundbreaking research into a rare form of leukaemia, proving the effectiveness in patients of non-chemotherapy-based treatments that target the genetic cause of the disease. The Hairy Cell Leukemia project, launched by the Institute of Hematology at the University of Perugia in Italy with funding from the European Research Council, is one of the world’s foremost initiatives to develop a targeted therapy for hairy cell leukaemia (HCL), a rare form of blood cancer.
If Darwin could have scuba dived, he would have enjoyed the East African lakes: Victoria, Malawi and Tanganyika. Here live the cichlids – a colourful fish which has evolved rapidly into thousands of species, emulating and surpassing Darwin's finches in the Galapagos. Prof. Walter Salzburger, an Austrian researcher, is using his ERC grants to study the diversity of cichlids from ecological, morphological and genetic viewpoints. He believes these unique fish provide an ideal model system to understand the "how" and the "why" in questions of evolutionary biology: questions that relate to all life on earth.
Assisted Reproductive Technology (ART) is increasingly used to help women become pregnant. The most common technique is in vitro fertilisation, i.e. the transfer of fertilised human eggs into a woman's uterus. However, ART can imply risks for the embryo during the pregnancy or even later in life. With a grant of the European Research Council (ERC), Polish researcher Dr Grazyna Ewa Ptak has analysed sheeps embryos. With her team at the University of Teramo, she has discovered the precise timing and nature of placental disorders consequent to ART. Her findings can greatly improve reproductive technologies and lead to safer pregnancies for both women and animals.